STARPHARMA HOLDINGS

SPL
End-of-day quote. End-of-day quote  - 11/26
1.075AUD -7.73%
Valuation
Fiscal Period: June 2020 2021
Capitalization1 419607
Entreprise Value (EV)1 391548
P/E ratio -28,1x-29,9x
Yield --
Capitalization / Revenue 63,9x282x
EV / Revenue 59,6x255x
EV / EBITDA -26,1x-26,4x
Price to Book 13,4x9,74x
Nbr of stocks (in thousands) 372 563406 078
Reference price (AUD) 1,131,50
Announcement Date 08/25/202108/25/2021
Previous period Next period
1 AUD in Million
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: June 2020 2021
Net sales1 6,562,15
EBITDA1 -15,0-20,8
Operating profit (EBIT)1 -15,2-21,1
Operating Margin -232%-979%
Pre-Tax Profit (EBT)1 -14,7-19,7
Net income1 -14,7-19,7
Net margin -224%-917%
EPS2 -0,04-0,05
Dividend per Share --
Announcement Date 08/25/202108/25/2021
Previous period Next period
1 AUD in Million
2 AUD
Finances - Leverage
Fiscal Period: June 2020 2021
Net Debt1 --
Net Cash position1 28,559,3
Leverage (Debt / EBITDA) 1,90x2,86x
Free Cash Flow1 -5,50-8,73
ROE (Net Profit / Equities) -39,8%-42,2%
Shareholders' equity1 36,946,8
ROA (Net Profit / Asset) -21,7%-23,4%
Assets1 67,884,2
Book Value Per Share2 0,080,15
Cash Flow per Share2 0,080,15
Capex1 0,130,25
Capex / Sales 1,91%11,4%
Announcement Date 08/25/202108/25/2021
Previous period Next period
1 AUD in Million
2 AUD
EPS & Dividend